Press release
Anatomic Pathology Market Is Anticipated To Reach USD 69.6 Billion In 2033
Anatomic Pathology Market
Anatomical pathology is the branch of medicine that comprises the study of body organs and tissues. Anatomical pathology is considered one of the diagnostic branches of medicine, coupled with radiology and other pathology specialties (such as microbiology and chemical pathology).
Market Outlook
The global anatomic pathology market size was USD 35.6 Bn in 2021 and is anticipated to reach USD 69.6 Bn in 2031, growing at a rate of 6.9% from 2022 to 2031.
Anatomical pathology is the branch of medicine that comprises the study of body organs and tissues. Anatomical pathology is considered one of the diagnostic branches of medicine, coupled with radiology and other pathology specialties (such as microbiology and chemical pathology). Its roles comprise determining the cause of certain diseases and the effect that they are having on the body, assisting with the choice of treatment that will be given, aiding in giving a prognosis, and determining what may have caused a person's death.
Rising incidence of cancer and other target diseases
Cancer is a leading cause of death across the globe, which accounts for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancer are breast, lung, colon , and prostate cancers. Around one-third of cancer deaths are due to tobacco use, high body mass index, alcohol consumption, low fruit and vegetable intake, and lack of physical activity. Like HPV and hepatitis, cancer-causing infections are responsible for approximately 30% of cancer cases in low and lower-middle-income countries. Many cancers can be cured if detected early and treated effectively.
The increasing number of clinical trials pertaining to cancer drugs
Anatomic pathology products and services are used in oncology drug trials to analyze quantitative information as well as to detect morphological structures, detect pharmacodynamic markers, and understand drug mechanisms. It is also used to stratify trial subjects based on the responses given by tissues to the drugs. Tissue diagnostics thus facilitate efficient trials and retrospective studies by reducing the cost and time involved in these processes. For instance, in a Phase III study for Roche's cancer immunotherapy-TECENTRIQ (atezolizumab)-the PD-L1 (programmed death-ligand 1) expression was evaluated using an investigational immunohistochemistry (IHC) test, which was developed by Roche Tissue Diagnostics.
To Know More: https://www.globalinsightservices.com/reports/anatomic-pathology-market/?utm_id=1017
Research Objectives
• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Request Sample: https://www.globalinsightservices.com/request-sample/GIS10238/?utm_id=1017
The increasing number of clinical trials pertaining to cancer drugs
Anatomic pathology products and services are used in oncology drug trials to analyze quantitative information as well as to detect morphological structures, detect pharmacodynamic markers, and understand drug mechanisms. It is also used to stratify trial subjects based on the responses given by tissues to the drugs. Tissue diagnostics thus facilitate efficient trials and retrospective studies by reducing the cost and time involved in these processes. For instance, in a Phase III study for Roche's cancer immunotherapy-TECENTRIQ (atezolizumab)-the PD-L1 (programmed death-ligand 1) expression was evaluated using an investigational immunohistochemistry (IHC) test, which was developed by Roche Tissue Diagnostics.
Request Customization: https://www.globalinsightservices.com/request-customization/GIS10238/?utm_id=1017
Market Players of Global Anatomic Pathology Market
The key players in the global anatomic pathology market are F. Hoffmann-La Roche AG, Danaher Corporation, PHC Holdings Corporation, Beckton, Dickson and Company, Abcam plc., Hologic, Inc., Agilent Technologies, Merck KGaA, Sakura Finetek, Bio SB, BioGenex, Milestone Medical, Histo-Line Laboratories, Diapath S.p.A, SLEE medical GmbH, Amos Scientific Pty Ltd, MEDITE Medical GmbH, Cell Signaling Technology, Inc., CellPath Ltd., Jinhua Yidi Medical Equipment Co., Ltd., MICROS AUSTRIA, R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED, Lupetec, Medimeas, and Bright Instruments among others.
Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS10238/?utm_id=1017
Research Scope
• Scope - Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing - Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics - Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework - Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape - Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles - Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
• Market Size in 2024 - US$ 35.6 Billion
• Market Size in 2033 - US$ 69.6Billion
• CAGR - 6.9%
• Historic Period - 2015-2022
• Forecast Period - 2024-2033
• Base Year - 2024
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10238/?utm_id=1017
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
•Unmatched data quality and after sales service
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anatomic Pathology Market Is Anticipated To Reach USD 69.6 Billion In 2033 here
News-ID: 3349261 • Views: …
More Releases from Global Insight Services
Risk Management Software Market Is Anticipated To Expand From $14.9 Billion In 2 …
Market Overview
The Risk Management Software Market is becoming an essential pillar for organizations across industries as they navigate an increasingly complex business environment. Companies face rising challenges ranging from regulatory compliance and cybersecurity threats to operational inefficiencies and supply chain disruptions. Risk management software provides a unified solution to identify, monitor, and mitigate these risks, enabling organizations to make informed decisions while safeguarding business continuity. These tools are not limited…
Rare Disease Treatment Market Expected to Grow from $213.5 Billion in 2024 to $5 …
The Rare Disease Treatment Market is emerging as one of the most dynamic sectors in the global healthcare landscape. This market focuses on the development, production, and distribution of therapies designed to address rare and complex medical conditions affecting a small percentage of the population. Rare diseases, often genetic in origin, pose significant treatment challenges, which has prompted biopharmaceutical companies to invest in innovative solutions such as orphan drugs, gene…
Digital Health Coaching Market Expected to Grow from $10.7 Billion in 2024 to $3 …
The Digital Health Coaching Market is revolutionizing the healthcare and wellness landscape by offering personalized guidance through digital platforms. This market encompasses mobile applications, web-based platforms, and wearable devices that integrate artificial intelligence, data analytics, and behavioral science to provide tailored health programs. From chronic disease management to mental health support and nutrition coaching, digital health coaching empowers individuals to achieve their health goals conveniently and efficiently. The growing emphasis…
Real-world Evidence (Rwe) Market Is Anticipated To Expand From $18.6 Billion In …
Market Overview
The Real-World Evidence (RWE) Market is becoming a cornerstone of modern healthcare, revolutionizing the way data is used to inform treatment decisions, drug development, and regulatory approvals. Unlike traditional clinical trials, which are conducted under controlled conditions, real-world evidence captures insights from everyday healthcare settings such as electronic health records, insurance claims, patient registries, and wearable devices. This approach provides a more comprehensive picture of how therapies perform in…
More Releases for Anatomic
Anatomic Pathology Market: Trends Shaping the Future of Diagnostics
The global Anatomic Pathology market has witnessed impressive growth over the past few years, with substantial technological advancements, increased diagnostic needs, and a surge in healthcare spending across the globe. The demand for precision medicine, combined with the rise of personalized treatments, has further accelerated the importance of anatomic pathology in diagnosing diseases, particularly cancer, infections, and autoimmune disorders. In this comprehensive report, we will explore the market dynamics, growth…
Anatomic Pathology Market Trend And Opportunities By Forecast 2028
According to Premium Market Insights new research study on "Anatomic Pathology Market is expected to grow from US$ 22,800.20 million in 2022 to US$ 33,145.78 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.
Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00009138/?utm_source=OpenPR&utm_medium=10655
Some Of the Major Players Influencing are F. Hoffmann-La Roche Ltd., Danaher, Hologic, Inc., Agilent Technologies, Inc., BioGenex, Diapath S.p.A., Bio SB,…
Anatomic Pathology Market Size, CAGR | Growth - 2030
Exclusive Report by Ameco Research: Anatomic Pathology Market Size Projected to Reach USD 32 Billion by 2030, Growing at 6.50% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Anatomic Pathology Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Why Are Diagnostic Laboratories Using Anatomic Pathology Products?
The World Health Organization (WHO) estimates that nearly 1.28 billion people aged 30–79 years are currently living with hypertension, and nearly two-thirds of this population reside in low- and middle-income countries. The organization also reveals that nearly 17.9 million human lives were lost due to cardiovascular diseases (CVDs), such as heart attack and stroke, globally in 2019. Further, the International Agency for Research on Cancer (IARC) states that 19,292,789 people…
Anatomic Pathology Market Trends, Size, Forecast - 2019-2025
The global anatomic pathology market is expected to grow at a CAGR of 6%, during the forecast period. Anatomy pathology is the branch of medicines in which the effect of disease on the body organs are studied as a whole or microscopically. The key applications include identification of the abnormalities that aids in diagnosis and managing the treatment of diseases. One of the key applications of the anatomic pathology includes…
Global Anatomic Pathology Market Research Report
This report studies the global Anatomic Pathology market status and forecast, categorizes the global Anatomic Pathology market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Agilent Technologies, Inc. Bio SB Biogenex Laboratories Danaher Corporation F. Hoffmann-La Roche AG. Laboratory Corporation of America…
